Biobanks and the Advancement of Cancer Research
Explore how biobank research and oncology biobanking support cancer research through high-quality tumor tissue samples, cancer biomarkers, and genetic analysis, advancing personalized medicine and guiding treatment decisions in modern oncology.
Biobanks are essential to advancing cancer research and the future of personalized oncology by collecting and preserving high-quality biological samples, including tumor tissue samples, blood plasma, and DNA extracts. Biobank research enables scientists to investigate how genetic mutations contribute to disease onset, progression, and treatment response.
In particular, oncology biobanking supports precision medicine by making annotated biospecimens available for in-depth analysis. Researchers use these materials to identify cancer biomarkers, study tumor behavior, and validate molecular tests. Whether analyzing tumor cells from prostate cancer, solid tumor samples from colorectal cancer, or blood-derived liquid biopsies, biobanks provide the foundation for evidence-based cancer care.
The Role of Oncology Biobanking
Oncology biobanking systematically collects and stores samples directly relevant to cancer detection and treatment. This includes tumor tissues, matched blood samples, and associated clinical data. These materials are used to uncover molecular signatures that inform diagnosis and therapeutic strategies.
For example, researchers may track prostate-specific antigen (PSA) levels in prostate cancer or profile gene expression in aggressive cancers like small cell lung carcinoma. By linking tumor tissue samples to patient histories and outcomes, oncology biobanking helps identify tumor markers, monitor disease progression, and develop targeted therapies.
Biobanks also serve as critical infrastructure for long-term studies. Standardized sample handling protocols allow scientists to compare specimens across populations and timepoints. This consistency enhances the reliability of results and makes it easier to detect novel cancer biomarkers, including those tied to rare or early-stage cancers.
Many oncology biobanks follow international standards to ensure quality and reproducibility, including ISO 20387:2018, and in the United States, CAP and CLIA for clinical work. ISBER Best Practices are widely used guidelines that inform site-specific SOPs. Hamilton systems support these frameworks with automation that standardizes sample processing, labeling, and storage from the point of collection onward.
Advancing Personalized Medicine Through Biobank Research
Biobanks play a vital role in the development of personalized cancer therapies. By studying genetic mutations in diverse tumor tissue samples, researchers can uncover patterns that lead to improved classification of cancer subtypes, more accurate prognoses, and tailored treatment regimens.
A key application of biobank research is the validation of molecular testing platforms. For instance, assays based on Polymerase Chain Reaction (PCR) and Next-Generation Sequencing (NGS) require well-characterized biological material to determine sensitivity, specificity, and clinical utility. When validated against tumor tissues from biobanks, these tools can reliably detect cancer biomarkers from small blood samples, reducing the need for invasive biopsies.
Biobank samples are also essential for combining insights from multiple data types. Integrated analysis of solid tumor specimens, circulating tumor DNA (ctDNA), and transcriptomic profiles creates a more complete picture of cancer biology and treatment response.
Hamilton supports this work by providing automation tools that preserve sample integrity and eliminate human error across high-throughput workflows.
Hamilton’s Role in Biobanking Research Workflows
Hamilton offers comprehensive solutions for every stage of oncology biobanking—from initial sample intake to long-term storage and downstream analysis.
Automation platforms like the Microlab STAR enable high-throughput processing of tumor tissues, blood samples, and DNA extracts. These systems ensure accurate labeling, aliquoting, and archiving, all while minimizing manual handling that can introduce variability or contamination.
In research environments where sample integrity and traceability are critical, Hamilton Instruments maintains consistency across multiple biobanking tasks:
- Sample intake and barcode labeling
- DNA/RNA extraction
- Quality control analysis
- Cryopreservation and -80°C storage
- LIMS integration and audit trail tracking
Hamilton also provides tailored workflow solutions through its “Custom Built” program. By working directly with laboratories, we help design flexible systems that meet the specific needs of academic research centers, clinical labs, and pharmaceutical biobanks.
What is a Biobank in Research?
A biobank is a secure repository where biological specimens—such as tumor tissues, blood samples, and DNA—are collected, processed, stored, and made available for scientific study. In the context of oncology biobanking, these samples are paired with detailed patient data, including diagnosis, treatment history, demographics, and clinical outcomes.
This rich combination of sample and metadata allows researchers to:
- Investigate how somatic mutations contribute to cancer
- Identify and validate emerging cancer biomarkers
- Study tumor heterogeneity and clonal evolution
- Refine cancer classification systems
- Evaluate treatment efficacy and adverse responses
For example, tumor tissue samples from patients with ovarian or colorectal cancer can reveal how specific mutations correlate with survival or drug resistance. These insights directly influence the development of diagnostic tests and targeted therapies.
To support research at this level, biobanks require consistent sample handling, robust data annotation, and ultra-low temperature storage—all of which can be streamlined using Hamilton’s integrated systems.
How Does Biobanking Work?
Biobanking follows a standardized workflow to ensure that every sample collected is useful for current or future studies. In oncology settings, this process typically includes:
01
Informed Consent
Patients voluntarily donate biological samples for research, with consent forms outlining use, privacy, and governance.
02
Sample Collection
Biological materials such as solid tumor biopsies, blood plasma, or buffy coats are collected using clinical protocols.
03
Sample Processing
Hamilton automation systems help aliquot, label, and prepare these samples under sterile, controlled conditions to avoid degradation.
04
Data Annotation
Each sample is paired with clinical metadata, including diagnosis, cancer stage, biomarkers such as HER2 and KRAS, and treatment information. This data is typically managed and stored in a LIMS or BIMS to ensure traceability and consistent records.
05
Storage
Samples are cryopreserved at temperatures from -20°C to -196°C, depending on material and use case. Hamilton automated storage solutions enable fast retrieval and robust inventory control, and via API they link storage history and exact location data in the system directly to a LIMS or BIMS for end-to-end traceability.
06
Access and Retrieval
Researchers request specific tumor samples or cohorts through a governance workflow managed in the LIMS. When access is granted, the automated store’s RESTful API triggers pick jobs from the LIMS, streamlining retrieval and maintaining a complete audit trail.
07
Analysis and Reuse
Multiple studies may use samples, from molecular assays to biomarker validation and drug development programs.
By using automated, LIMS-integrated systems, Hamilton enables consistent processing that meets the needs of modern oncology studies and complies with global quality standards.
Enabling the Next Generation of Cancer Research
The future of cancer research depends on high-quality, well-annotated biological samples. Biobanks must scale to support increasingly complex studies as scientific tools evolve, especially in single-cell analysis, spatial transcriptomics, and multi-omics integration.
Hamilton’s automation technologies are built to evolve with these demands. From the benchtop to the biobank freezer, our solutions support:
- Higher throughput with reduced error rates
- Flexible integration with LIMS and clinical databases
- Better long-term sample preservation
- Seamless compatibility with PCR, NGS, and mass spectrometry workflows
- Compliance with research and clinical quality standards
Hamilton is committed to partnering with researchers, clinicians, and biobank managers to enable more accurate, scalable, and cost-efficient cancer studies. Whether your team is launching a new oncology biobank or upgrading your existing infrastructure, we provide the trusted tools and support you need to succeed.